SEARCH

SEARCH BY CITATION

References

  • Adams JM, Cory S. 1998. The Bcl-2 protein family: Arbiters of cell survival. Science 281: 13221325.
  • Bax A, Clore GM, Gronenborn AM. 1990. 1H-1H correlation via isotropic mixing of 13C magnetization, a new three-dimensional approach for assigning 1H and 13C spectra of 13C-enriched proteins. J Magn Reson 88: 425431.
  • Brünger AT. 1992. X-PLOR version 3.1 manual. New Haven, Connecticut: Yale University Press.
  • Carson M. 1987. Ribbon models of macromolecules. J Mol Graphics 5: 103106.
  • Cornilescu G, Delaglio F, Bax A. 1999. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13: 289302.
  • Dandliker WB, Hsu ML, Levin J, Rao BR. 1981. Equilibrium and kinetic inhibition assays based upon fluorescence polarization. Methods Enzymol 74: 328.
  • Fesik SW, Zuiderweg ERP. 1988. Heteronuclear three-dimensional NMR spectroscopy. A strategy for the simplification of homonuclear two-dimensional spectra. J Magn Reson 78: 588593.
  • Furet P, García-Echeverria C, Gay B, Schoepfer J, Zeller M, Rahuel J. 1999. Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-Sh2 domain containing an asparagine mimetic. J Med Chem 42: 23582363.
  • Grzesiek S, Bax A. 1993. The orign and removal of artifacts in 3D HCACO spectra of proteins uniformly enriched with 13C. J Magn Reson Series B 102: 103106.
  • Kelekar A, Chang BS, Harlan JE, Fesik SW, Thompson CB. 1997. Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-xL. Mol Cell Biol 17: 70407046.
  • Lakowicz JR. 1983. Principles of fluorescence spectroscopy. New York: Plenum Press.
  • Laskowski RA, Rullmann JA, MacArthur MW, Kaptein R, Thornton JM. 1996. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8: 477486.
  • Logan TM, Olejniczak ET, Xu RX, Fesik SW. 1992. Side chain and backbone assignments in isotopically labeled proteins from two heteronuclear triple resonance experiments. FEBS Lett 314: 413418.
  • Matthews DA, Dragovich PS, Webber SE, Fuhrman SA, Patick AK, Zalman LS, Hendrickson TF, Love RA, Prins TJ, Marakovits JT, et al. 1999. Structure-assisted design of mechanism-based irreversible inhibitors of human rhino-virus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci USA 96: 1100011007.
  • Meyers JK, Pace CN, Scholtz JM. 1997. Helix propensities are identical in proteins and peptides. Biochemistry 36: 1092310929.
  • Minn AJ, Swain RE, Ma A, Thompson CB. 1998. Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv Immunol 70: 245279.
  • Montelione GT, Lyons BA, Emerson SD, Tashiro M. 1992. An efficient triple resonance experiment using carbon-13 isotropic mixing for determining sequence-specific resonance assignments of isotopically-labeled proteins. J Am Chem Soc 114: 1097410975.
  • Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, et al. 1996. X-ray and NMR structure of Human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335341.
  • Muñoz V, Serrano L. 1995a. Elucidating the folding problem of helical peptides using empirical parameters, II: Helix macrodipole effects and rational modification of the helical content of natural peptides. J Mol Biol 245: 275296.
  • Muñoz V, Serrano L. 1995b. Elucidating the folding problem of helical peptides using empirical parameters, III: Temperature and pH dependence. J Mol Biol 245: 297308.
  • Neri D, Szyperski T, Otting G, Senn H, Wüthrich K. 1989. Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling. Biochemistry 28: 75107516.
  • Ottilie S, Diaz JL, Horne W, Chang J, Wang Y, Wilson G, Chang S, Weeks S, Fritz LC, Oltersdorf T. 1997. Dimerization properties of human Bad—Identification of a BH-3 domain and analysis of its binding to mutant Bcl-2 and Bcl-xL proteins. J Biol Chem 272: 3086630872.
  • Rohl CA, Chakrabartty A, Balwin RL. 1996. Helix propagation and N-cap propensities of the amino acids measured in alanine-based peptides in 40 volume percent trifluoroethanol. Protein Sci 5: 26232637.
  • Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan J, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, et al. 1997. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 275: 983986.
  • Shakespeare W, Yang M, Bohacek R, Cerasoli F, Stebbins K, Sundaramoorthi R, Azimioara M, Vu C, Pradeepan S, Metcalf C III, et al. 2000. Structure-based design of an osteoclast-selective, nonpeptide Src homology 2 inhibitor with in vivo antiresorptive activity. Proc Natl Acad Sci USA 97: 93739378.
  • Stark GR. 1977. Cleavage at cysteine after cyanylation. Methods Enzymol 47: 129132.
  • Stein EG, Rice LM, Brünger AT. 1997. Torsiona angle molecular dynamics: a new efficient tool for NMR structure calculation. J Magn Reson Ser B 124: 154164.
  • Yamazaki T, Lee W, Arrowsmith CH, Muhandiram DR, Kay LE. 1994. A suite of triple resonance NMR experiments for the backbone assignment of 15N, 13C, 2H labeled proteins with high sensitivity. J Am Chem Soc 116: 1165511666.
  • Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. 1995. Bad, a heterodimeric partner for Bcl-xL and BcL-2, displaces Bax and promotes cell death. Cell 80: 285291.